We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$157M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$112M
3
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$109M
4
USMV icon
iShares MSCI USA Min Vol Factor ETF
USMV
+$73.1M
5
T icon
AT&T
T
+$64.5M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$134M
2
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$73.7M
3
DD icon
DuPont de Nemours
DD
+$64.2M
4
CCI icon
Crown Castle
CCI
+$45.2M
5
CSCO icon
Cisco
CSCO
+$42M

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NOVN
3426
DELISTED
Novan, Inc. Common Stock
NOVN
$70K ﹤0.01%
2,604
– –
HMHC
3427
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$70K ﹤0.01%
12,138
-176,631
-94% -$1.17M
DSE
3428
DELISTED
Duff & Phelps Select MLP and Midstream Energy Fund Inc.
DSE
$69K ﹤0.01%
1,418
+80
+6% +$3.98K
GNMK
3429
DELISTED
GenMark Diagnostics, Inc
GNMK
$69K ﹤0.01%
+10,600
New +$74.7K
MOBL
3430
DELISTED
MobileIron, Inc.
MOBL
$69K ﹤0.01%
+11,080
New +$62.7K
CLMT icon
3431
Calumet Specialty Products
CLMT
$3.44B
$68K ﹤0.01%
16,327
-372
-2% -$1.49K
AAU
3432
DELISTED
Almaden Minerals Ltd
AAU
$68K ﹤0.01%
115,524
+600
+0.5% +$314
GEN
3433
DELISTED
Genesis Healthcare, Inc.
GEN
$68K ﹤0.01%
55,000
– –
CPRX
3434
DELISTED
Catalyst Pharmaceutical
CPRX
$67K ﹤0.01%
17,507
+4,500
+35% +$19.4K
GPRO icon
3435
GoPro
GPRO
$126M
$67K ﹤0.01%
12,357
-410
-3% -$2.61K
STON
3436
DELISTED
StoneMor Inc.
STON
$67K ﹤0.01%
30,318
-13,861
-31% -$41.1K
RESN
3437
DELISTED
Resonant Inc.
RESN
$67K ﹤0.01%
+28,225
New +$79.1K
FOMX
3438
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$67K ﹤0.01%
28,000
– –
IWM icon
3439
CALL
iShares Russell 2000 ETF
IWM
$81.9B
$66K ﹤0.01%
50,300
-1,600
-3% -$247K
ALPN
3440
DELISTED
Alpine Immune Sciences Inc
ALPN
$66K ﹤0.01%
15,641
+1,897
+14% +$11K
GME icon
3441
GameStop
GME
$8.6B
$65K ﹤0.01%
47,660
+3,312
+7% +$6.48K
ACH
3442
Accendra Health
ACH
$214M
$65K ﹤0.01%
20,244
+72
+0.4% +$246
WPG
3443
DELISTED
Washington Prime Group Inc.
WPG
$64K ﹤0.01%
+1,848
New +$75.8K
MDT icon
3444
CALL
Medtronic
MDT
$112B
$63K ﹤0.01%
+103,300
New +$9.43M
DMK
3445
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$62K ﹤0.01%
681
+22
+3% +$2.68K
INAP
3446
DELISTED
Internap Corporation
INAP
$62K ﹤0.01%
20,649
+562
+3% +$2K
CMRE icon
3447
Costamare
CMRE
$1.77B
$61K ﹤0.01%
11,867
-5,781
-33% -$31.7K
LLEX
3448
DELISTED
Lilis Energy, Inc. Common Stock
LLEX
$61K ﹤0.01%
+100,000
New +$93.6K
AAN.A
3449
CALL
DELISTED
The Aaron's Company Inc Class A
AAN.A
$61K ﹤0.01%
13,500
– –
MET icon
3450
CALL
MetLife
MET
$62.1B
$60K ﹤0.01%
59,500
+12,600
+27% +$592K
136 137
138
139 140

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.